Concepedia

Antonia Cagnetta

AC

24

Publications

2.3K

Citations

19

H-Index

2011

Active since

Affiliations

Ospedale Policlinico San Martino(Current)

Dana-Farber Cancer Institute

University of Genoa

Harvard University

Istituti di Ricovero e Cura a Carattere Scientifico

Antonia Cagnetta is an author at Ospedale Policlinico San Martino specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2011–2023

24

Publications

24

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

Yu‐Tzu Tai, Patrick A. Mayes, Chirag Acharya et al. · Blood · 2014 · 472 citations

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Yu‐Tzu Tai, Chirag Acharya, Gang An et al. · Blood · 2016 · 347 citations · Full text

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

Y-T Tai, Yosef Landesman, Chirag Acharya et al. · Leukemia · 2013 · 299 citations · Full text

, , +10

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Yu‐Tzu Tai, Betty Chang, Sun‐Young Kong et al. · Blood · 2012 · 165 citations · Full text

Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti et al. · Blood · 2012 · 138 citations · Full text

Rows per page

1–5 of 24